THE VOICE OF ONCOLOGY IN FLORIDA FLASCO is a member supported state society that focuses on providing education, advocacy, communication and general support of the Florida professionals who have chosen the challenging medical discipline of oncology. UPCOMING EVENTS CORPORATE MEMBERSHIP BENEFITS BENEFITS FOR ONCOLOGY PROFESSIONALS FLASCO

Latest News & Updates

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
March 4, 2021

Continue Reading »

FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma
March 1, 2021

Continue Reading »

FDA approves Regeneron, Sanofi’s Libtayo for first-line advanced NSCLC with high PD-L1 expression
February 25, 2021

Continue Reading »

FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression
February 22, 2021

Continue Reading »

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
March 4, 2021

Continue Reading »

Now Approved: PEPAXTO® (melphalan flufenamide); Oncopeptides, Inc.
March 4, 2021

Continue Reading »

FDA Expands Approval of Lorlatinib for Frontline ALK-Positive NSCLC
March 4, 2021

Continue Reading »

FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma
March 1, 2021

Continue Reading »

Get More from FLASCO With Your Membership

The Corporate Membership Program allows FLASCO to expand our offerings to our membership. Every FLASCO meeting also provides the industry representative with opportunities to educate our members. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Members:

We're Here to Help Contact Us

Contact Us

Add your name, email & message below: